Max Bayer is a staff reporter at Endpoints News covering all angles of the industry with a focus on restructuring and shifting R&D efforts. Prior to joining Endpoints, Max was with Fierce Biotech where he covered the biotech industry and new drug development. He's broken stories on some of the largest pharmaceutical companies and nailed down pipeline plans for budding biotechs. Earlier in his career, Max covered the twists and turns of the COVID-19 pandemic for CBS News, reporting on federal health policy and the national vaccination effort. He's based in Brooklyn, New York and can often be found rooting on Bay Area sports team or biking through the city (with a helmet on, of course!).